13F filer · CIK 2038158
NEXTBio Capital Management LP
AUSTIN, TX · filing since Q4 2025 · last filing Aug 14, 2026
Reported value
$217.4M
+$2.0M vs prior
Positions
22
New / sold out
3 / 5
Added / reduced
7 / 5
Turnover
13.0%
buys $28.2M · sells $52.3M
Top-10 weight
77.7%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | STRUCTURE THERAPEUTICS INC | +179,257 | +134.5% | +$9.6M |
| Added | SHATTUCK LABS INC | +577,441 | +18.3% | +$4.0M |
| New | PHARVARIS N V | +108,055 | – | +$3.7M |
| New | BIOAGE LABS INC | +100,732 | – | +$2.5M |
| New | LB PHARMACEUTICALS INC | +68,249 | – | +$2.2M |
| Added | ORIC PHARMACEUTICALS INC | +182,505 | +34.9% | +$2.0M |
| Added | INVENTIVA SA | +454,500 | +34.1% | +$1.7M |
| Added | PALVELLA THERAPEUTICS INC NE | +7,223 | +8.7% | +$1.1M |
| Added | VAXCYTE INC | +12,000 | +12.6% | +$697.6K |
| Added | RHYTHM PHARMACEUTICALS INC | +5,680 | +4.5% | +$630.7K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | TERNS PHARMACEUTICALS INC | -604,534 | -100.0% | $-31.9M |
| Sold out | COMPASS THERAPEUTICS INC | -848,204 | -100.0% | $-4.5M |
| Sold out | OCULIS HOLDING AG | -149,592 | -100.0% | $-4.0M |
| Reduced | COMPASS PATHWAYS PLC | -245,648 | -12.2% | $-3.5M |
| Sold out | KALVISTA PHARMACEUTICALS INC | -131,796 | -100.0% | $-2.7M |
| Reduced | VOR BIOPHARMA INC | -110,803 | -11.1% | $-2.0M |
| Sold out | SUMMIT THERAPEUTICS INC | -89,717 | -100.0% | $-1.7M |
| Reduced | PROTAGONIST THERAPEUTICS INC | -10,286 | -4.5% | $-1.3M |
| Reduced | EVOMMUNE INC | -65,000 | -35.3% | $-863.8K |
| Reduced | COGENT BIOSCIENCES INC | -113 | -0.1% | $-4.4K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PROTAGONIST THERAPEUTICS INCCOM | 219,333 | $26.9M | 12.37% |
| 2 | SHATTUCK LABS INCCOM | 3,727,348 | $25.9M | 11.90% |
| 3 | COMPASS PATHWAYS PLCSPONSORED ADS | 1,775,759 | $25.1M | 11.56% |
| 4 | STRUCTURE THERAPEUTICS INCSPONSORED ADS | 312,496 | $16.8M | 7.71% |
| 5 | VOR BIOPHARMA INCCOM NEW | 889,164 | $16.4M | 7.53% |
| 6 | RHYTHM PHARMACEUTICALS INCCOM | 131,758 | $14.6M | 6.73% |
| 7 | PALVELLA THERAPEUTICS INC NECOM | 89,909 | $13.7M | 6.32% |
| 8 | XENON PHARMACEUTICALS INCCOM | 183,225 | $11.1M | 5.09% |
| 9 | ZENAS BIOPHARMA INCCOM | 426,736 | $10.8M | 4.98% |
| 10 | ORIC PHARMACEUTICALS INCCOM | 706,124 | $7.6M | 3.52% |
12 more rows. Subscribe for $29/month to see every row, download the data and use the API.